CureVac NV (CVAC)
3.89
+0.12
(+3.18%)
USD |
NASDAQ |
May 31, 16:00
3.88
-0.01
(-0.26%)
After-Hours: 20:00
CureVac Gross Profit (Quarterly): -31.84M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -31.84M |
| December 31, 2023 | -33.42M |
| September 30, 2023 | -8.490M |
| June 30, 2023 | -19.93M |
| March 31, 2023 | -14.51M |
| December 31, 2022 | -69.85M |
| September 30, 2022 | -12.96M |
| June 30, 2022 | -24.00M |
| March 31, 2022 | -14.43M |
| December 31, 2021 | -32.93M |
| Date | Value |
|---|---|
| September 30, 2021 | -101.02M |
| June 30, 2021 | -18.08M |
| March 31, 2021 | -6.905M |
| December 31, 2020 | -1.291M |
| September 30, 2020 | 3.729M |
| June 30, 2020 | 38.49M |
| March 31, 2020 | -2.600M |
| December 31, 2019 | -2.541M |
| September 30, 2019 | -6.564M |
| March 31, 2019 | -5.000M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-101.02M
Minimum
Sep 2021
38.49M
Maximum
Jun 2020
-18.90M
Average
-14.43M
Median
Mar 2022
Gross Profit (Quarterly) Benchmarks
| BioNTech SE | 139.58M |
| Affimed NV | -- |
| InflaRx NV | -0.2004M |
| MorphoSys AG | 47.84M |
| Immatics NV | -- |